InvestorsHub Logo
Followers 22
Posts 3693
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Sunday, 03/27/2022 9:54:28 AM

Sunday, March 27, 2022 9:54:28 AM

Post# of 183
AGAIN -

Collegium Pharmaceutical price target raised to $42 from $36 at Piper Sandler 02/22 COLL, BDSI Piper Sandler analyst David Amsellem raised the firm's price target on Collegium Pharmaceutical (COLL) to $42 from $36 and keeps an Overweight rating on the shares following the BioDelivery Sciences (BDSI) acquisition announcement. The analyst believes that visibility into EBITDA in excess of $300M by 2023 is relatively high.

Read more at:
https://thefly.com/n.php?id=3463057
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COLL News